Skip to content
  • Twitter
  • Facebook
  • DMCA
  • Privacy Policy
  • Terms of Use
Market Newswire

Market Newswire

The Latest Press Releases

  • Business Wire
  • PR Newswire
  • Globe Newswire
  • OpenPR
  • IssueWire
  • US Newswire
  • SEC Filings
  • Toggle search form

Immunic to Host Virtual Celiac Disease R&D Day to Highlight Current Pathways for Drug Development and Unmet Medical Need

Posted on February 9, 2023 By News Desk

Immunic, Inc. (Nasdaq: IMUX), a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies focused on treating chronic inflammatory and autoimmune diseases, announced that its Celiac Disease R&D Webcast will take place today, February 9, 2023 from 11:00 am to 1:00 pm ET. Management of Immunic, including Daniel Vitt, Ph.D., Chief Executive Officer and President; Andreas Muehler, M.D., M.B.A., Chief Medical Officer; and Hella Kohlhof, Ph.D., Chief Scienti(…..) Continue reading »

PR Newswire

Post navigation

Previous Post: BJ’s Wholesale Club Announces Continued Club Growth in 2023
Next Post: BORGWARNER DECLARES QUARTERLY DIVIDEND

Archives

  • March 2023
  • February 2023
  • January 2023
  • December 2022
  • November 2022
  • October 2022
  • September 2022
  • August 2022
  • July 2022
  • June 2022
  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • January 2022
  • December 2021
  • November 2021
  • October 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021

Categories

  • Business Wire
  • Globe Newswire
  • IssueWire
  • OpenPR
  • PR Newswire
  • SEC Filings
  • Uncategorized
  • US Newswire

Recent Posts

  • ROSEN, A TOP RANKED LAW FIRM, Encourages Signature Bank Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – SBNY, SBNYP
  • 8-K Emp Changes – DURECT CORP (0001082038) March 21
  • 8-K Other Events Material Agrmt – PhenomeX Inc. (0001689657) March 21
  • 8-K Other Events – Ellington Financial Inc. (0001411342) March 21
  • 8-K Reg FD – X4 Pharmaceuticals, Inc (0001501697) March 21

Copyright © 2023 Market Newswire.

Powered by PressBook WordPress theme

Go to mobile version